The latest healthcare and wellness news from Asia and the Pacific

Provided by AGP

Got News to Share?

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on April 22, 2026

What First-Time Patients Should Really Expect From a Colonoscopy or Gastroscopy
Family History May Move Colorectal Screening Earlier Than Expected
Trilio and Bigstack Announce Partnership to Deliver Advanced Data Protection in the Asia-Pacific Market
What Does the Competitive Landscape of the Healthcare Buildings Market Look Like
Peptide Therapeutics Contract API Manufacturing Market to Reach USD $4.12 Billion by 2030 at 7.4% CAGR
mRNA Therapeutics CDMO Market Competition Trends and Industry Positioning
Emergency Medical Services Software Market Competition Outlook and Player Positioning
Cellworks Presents Novel Mechanistic Approach to Predicting Drug–Drug Interaction Risk in Oncology at AACR 2026
Cellworks Expands Evidence for Predicting Chemo-Immunotherapy Benefit in NSCLC with New Early-Stage Disease Study
Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy Benefit in Advanced NSCLC
Victoria Basil Shines in NYC, Receiving Recognition Through the INDEPENDENT PRESS AWARD® and in NYC's Times Square
SafeLane Healthcare Drives Better NDIS Outcomes Through Person-Centred Support Coordination in Melbourne
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Racent Showcases sslTrus CLM at GOPS 2026, Highlighting Automated Certificate Management
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Communiqué de presse :  Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
THY精密工業、医療機器向けプラスチック部品のOEM生産体制を強化 ― ISO7・ISO8クリーンルームと自動化射出成形で高品質生産を実現

Share us

on your social networks:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.